Advances in Nanocarriers for Biofilm-Associated Infections
From Research to Clinical Practice
- 1 Edición - 10 de marzo de 2027
- Última edición
- Editores: Neeraj Mishra, Kuttiappan Anitha, Sumel Ashique
- Idioma: Inglés
Advances in Nanocarriers for Biofilm-Associated Infections: From Research to Clinical Practice addresses the critical challenge of treating biofilm-associated infections, which… Leer más
Descripción
Descripción
It equips researchers, clinicians, and pharmaceutical professionals to understand complex biofilm biology, apply novel drug delivery systems, and navigate clinical challenges, ultimately supporting the development of improved treatments for persistent biofilm-related infections.
Puntos claves
Puntos claves
- Explores nanocarrier technologies targeting biofilm-associated infections
- Bridges research and clinical applications of nanocarriers in infection control
- Highlights strategies to overcome antibiotic resistance using nanotechnology
- Discusses regulatory and translational challenges in nanocarrier therapies
- Presents future perspectives and innovative approaches in biofilm treatment
De interès para
De interès para
Índice
Índice
2. Mechanisms of Biofilm Resistance
3. Biofilms and multidrug resistance (MDR) in infections
4. Nanocarriers. Fundamentals and Applications
5. Design and Synthesis of Nanocarriers for Biofilm Penetration
6. Nanoparticles in Targeted Therapy for Biofilm-Associated Infections
7. Liposomal Nanocarriers in Biofilm Treatment
8. Dendrimers as Nanocarriers in Biofilm Control
9. Polymeric Micelles for Biofilm-Associated Infections
10. Nanocarrier Strategies for Overcoming Antibiotic Resistance
11. Nanocarriers in Biofilm-Associated Infections. Clinical Challenges, Regulatory Hurdles, and Translational Perspectives
12. Nanocarriers in the Treatment of Medical Device-Associated Infections
13. Nanocarriers in Chronic Wound Management
14. Nanotechnology in Respiratory Infections and Biofilm Control
15. Hurdles and challenges (clinical as well as regulatory) for applications nanocarriers in biofilm-associated infections
16. Clinical Practice of Biofilm-Associated Infections
17. Future Perspectives and Challenges in Nanocarrier-Based Biofilm Therapy
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Publicado: 10 de marzo de 2027
- Idioma: Inglés
Sobre los editores
Sobre los editores
NM
Neeraj Mishra
Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India. His academic work focuses on novel drug delivery systems, including localized, targeted, and controlled delivery approaches using nanocarrier and microparticle-based technologies. His research interests encompass therapies for cancer and neurodegenerative disorders, and he has extensive experience in teaching, research supervision, and scholarly publishing. He has also contributed to innovation in pharmaceutical sciences through intellectual property development and collaborative academic activities. Through his research and educational initiatives, he supports the advancement of drug delivery strategies and pharmaceutical research.
KA
Kuttiappan Anitha
Dr. Kuttiappan Anitha is working as Assistant Professor in School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience. Dr. Anitha is recipient of “Excellence in Academic Award” 2022 from International School of Technology and Sciences Affiliated from Govt. of India. She has guided more than 45 M.Pharm Students and more than 10 batches of UG Projects. She has more than 30 publications in both national and international journals. Her area of expertise includes Immunooncology, endocrine areas, Gut Microbiota, infectious Diseases. She has also written several books and many book chapters. She has organized Conferences/seminars at university levels.
SA
Sumel Ashique
Dr. Sumel Ashique has been working as an assistant professor at the Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, West Bengal, India. He has 5 years of teaching experience. He has achieved 100+ publications in international and national accredited reputed journals. He has expertise in drug delivery, nanotechnology, and targeted treatment strategies. Recently, he was honored to be in the World’s Top 2% Scientists by prestigious Stanford University, CA, United States, and Elsevier in 2025.